adarx.comHealthcareFounded: 2019Funding to Date: $152.5MM
ADARx Pharmaceuticals is a company that specializes in genetic medicine designed to treat human diseases and ailments using mRNA transcripts. ADARx researches and develops its therapies through oligonucleotides delivery technology. The firm focuses on three main disease treatments: genetic diseases, cardiometabolic diseases, and central nervous system (CNS) diseases.
View Enterprise Value for ADARx Pharmaceuticals.
